LENOIR, N.C.--(BUSINESS WIRE)--Nov. 7, 2005--Greer, a leading developer and provider of allergenic source materials and allergy immunotherapy products, is expanding its global reach and commitment to next-generation allergy care through a partnership with Danish biotechnology company Curalogic. Greer will supply Curalogic with customized source materials and analytical support for the development of its oral immunotherapy products.
